SOPHiA GENETICS SA
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2026 · Filed Aug 4, 2026
Use the contents to explore the available documents and sections.
SOPH$7.14+7.9%Stored close · as of Nov 6, 2026
Contents
EX-99.3 · (Amounts in USD thousands, except per share data)
(Amounts in USD thousands, except per share data)
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $23,310 | $18,323 | $44,998 | $36,102 |
| Cost of revenue | (8,249) | (6,053) | (15,188) | (11,624) |
| Gross profit | 15,061 | 12,270 | 29,810 | 24,478 |
| Research and development costs | (8,731) | (8,493) | (18,191) | (17,611) |
| Selling and marketing costs | (11,186) | (10,034) | (19,999) | (17,568) |
| General and administrative costs | (15,202) | (12,301) | (28,961) | (23,901) |
| Other operating income, net | 5 | 66 | 5 | 74 |
| Operating loss | (20,053) | (18,492) | (37,336) | (34,528) |
| Interest income | 231 | 419 | 520 | 869 |
| Interest expense | (1,620) | (559) | (3,287) | (1,218) |
| Fair value adjustments on warrant obligations | (317) | 58 | (409) | 20 |
| Foreign exchange losses, net | (519) | (3,078) | (835) | (3,677) |
| Loss before income taxes | (22,278) | (21,652) | (41,347) | (38,534) |
| Income tax expense | (78) | (762) | (331) | (1,265) |
| Loss for the period | (22,356) | (22,414) | (41,678) | (39,799) |
| Attributable to the owners of the parent | (22,356) | (22,414) | (41,678) | (39,799) |
| Basic and diluted loss per share | $(0.30) | $(0.33) | $(0.58) | $(0.59) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.